{"schema_version":"secwatch.filing_event.v1","accession":"0001682852-22-000020","form_type":"8-K","ticker":"MRNA","cik":"0001682852","company_name":"Moderna, Inc.","filed_at":"2022-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.826825+00:00","generated_at":"2026-06-26T00:48:11.179638+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Moderna Q1 revenue $6.1B, net income $3.7B; reiterates $21B 2022 APAs","bullets":["GAAP diluted EPS of $8.58 vs $2.84 YoY; revenue tripled to $6.1B from $1.9B.","Cost of sales 17% of product sales; R&D $554M, SG&A $268M.","Cash, equivalents, and investments $19.3B at quarter end; operating cash flow $2.8B.","Four programs in Phase 3 in Q2: Omicron bivalent COVID booster, flu, RSV, CMV.","CFO David Meline retiring; Jorge Gomez appointed CFO effective May 9, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001682852-22-000020","json":"https://secwatch.observer/filing/0001682852-22-000020.json","markdown":"https://secwatch.observer/filing/0001682852-22-000020.md","text":"https://secwatch.observer/filing/0001682852-22-000020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1682852/000168285222000020/0001682852-22-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1682852/000168285222000020/mrna-20220504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T00:48:11.179638+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}